UK incentives will attract more like us, says Eisai executive
This article was originally published in Scrip
Executive Summary
Measures announced in the UK Budget this week "have vindicated our decision to locate a hub in the UK" and will lead other pharmaceutical companies "to redirect investments to the UK now", Gary Hendler, president and CEO of Japanese pharma group Eisai's EMEA operations, told Scrip.